Randmized Controlled Trial of Prehabilitation in Patients Undergoing Cardiovascular Surgery

未提供0 个研究点目标入组 98 人开始时间: 待定

试验速览

暂无简介。

•1.Patients scheduled to undergo cardiovascular surgery requiring cardiopulmonary bypass or off-pump coronary artery bypass grafting (OPCAB) at Nara Medical University Hospital or Saiseikai Kumamoto Hospital.
•2.Patients with cardiovascular diseases classified as New York Heart Association (NYHA) functional class1or
•3.Patients aged 18 years or older, regardless of sex.
•4.Patients who can provide written informed consent.
•5.Patients who can complete a prehabilitation intervention period of at least 14 days before surgery.

•1.Patients undergoing emergency surgery.
•2.Patients with psychiatric disorders who are currently receiving treatment from a psychiatrist.
•Patients unable to communicate in Japanese in daily conversation.
•4.Patients with upper extremity paralysis or other conditions that make grip strength training or grip strength measurement impossible.
•5.Patients with a severe allergy to dairy products.
•6.Patients with severe obesity (BMI >=35 kg/m2) or poor glycemic control (HbA1c >= 8.0%) for whom nutritional supplementation is considered inappropriate or difficult.
•7.Patients with chronic kidney disease (CKD) stage 4 or 5 for whom protein supplementation is considered inappropriate or difficult.
•8.Patients with New York Heart Association (NYHA) functional class 3 or 4 heart failure.
•9.Patients with a history suggestive of symptomatic cerebral ischemia, such as syncope during exercise.
•10.Patients with a history of admission to an intensive care unit (ICU), including at another institution, within the past year.
•11.Patients who withdraw their informed consent after enrollment.
•12.Patients whose scheduled surgery is postponed by 7 days or more after enrollment, regardless of whether the reason is patient-related or hospital-related.
•13.Patients who undergo surgery with an intervention period of less than 14 days due to any reason.

发起方

未提供